Search Results for "Aria Diagnostics Inc"
Original Source: Aria Diagnostics
Aria Diagnostics, Inc., is a molecular diagnostics company committed to providing safe, highly accurate and affordable prenatal tests for maternal and fetal health. Led by an experienced team, Aria is using its proprietary technology to perform a directed analysis of cell-free DNA in blood. Ariaâs simple blood test equips pregnant women and their healthcare providers with reliable information to make decisions regarding their health, without creating unn...
Matching Channels
Diagnostics - news, views, blogs
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease...
Roche is the 5th largest pharmaceutical company in the world, based on annual sales, which were recorded at $36,017m in 2009. The pharmaceutical products of Roche are major players in the followin...
Alto Marketing - specialist healthcare and life science communications consultancy
Alto Marketing is a committed and forward-thinking specialist healthcare and life science communications consultancy. With extensive experience of worldwide marketing in sectors including (...
Siemens Healthcare is the second largest medical devices company in the world (based on annual sales), with sales of $17.4 billion. Specializing in the imaging, IT, diagnostics and workflow soluti...
In addition to the world famous Cambridge University, Cambridge and its surrounding area is a hub of globally reaching biotechnology companies. With more than 247 companies, and the high quality res...
Matching News
PropThink: Diagnostic Withdrawal Created Weakness in ARIA and an Opportunity for Investors
By Jake King Shares of ARIAD Pharmaceuticals (NASDAQ:ARIA) have been moving sporadically in the last week as traders test the limits of its latest range; ARIA set a new 52-week high la...
Ariad Sees Heavy Drop Following Spontaneous FDA Approval
By Brian L. Wilson:Last Friday we saw a bearish move in shares of Ariad Pharmaceuticals (NASDAQ: ARIA) on news that its drug Iclusig (ponatinib) was approved early by the FDA.The original PDUFA action...
Equity Brief: Ratings Changes for October 26th: ARIA, ARQL, ATHN, AZN, BCEI, BDE, BEN, BHE, BJRI
A number of stocks were upgraded and downgraded by equities research analysts today, as reported by Analyst Ratings Network(http://bit.ly/equitybriefdaily) and Equity Brief:Citigroup initiated coverag...
Court Denies Preliminary Injunction Motion Against Ariosa Diagnostics
SAN JOSE, Calif., July 6, 2012 /PRNewswire/ -- Ariosa Diagnostics, a molecular diagnostics company, announced today that the United States District Court for the Northern District of California denied...
Introducing Aria Post Acute Care
HILLSIDE, Ill., Oct. 22, 2012 /PRNewswire/ -- Effective October 1st, the Renaissance at Hillside will be renamed Aria Post Acute Care. Concurrent with the name change, the 198-bed facilit...
Miami’s ERBA Diagnostics, Inc. Acquires Escalon Medical Corp. Clinical Diagnostics Business
ERBA Diagnostics, a fully integrated in vitro diagnostics company, has acquired from Escalon Medical Corp. its Clinical Diagnostics Business for $6.5 million in cash. Revenues from the Escalon Clinica...
ERBA Diagnostics to showcase full range of products at AACC annual meeting
ERBA Diagnostics, Inc., a fully integrated in vitro diagnostics company, is pleased to announce that Suresh Vazirani, Chairman of ERBA Diagnostics, will be a key note speaker at the International Mark...
PrimeraDx, Quest Diagnostics to develop companion diagnostics
PrimeraDx, a molecular diagnostics company, has formed a non-exclusive diagnostics co-development agreement with Quest Diagnostics, a diagnostics information services company. The intent of the collab...
Matching PubMed Articles
Background: This study intended to assess the severity of Japanese cedar pollinosis using the Practical Guideline for the Management of Allergic Rhinitis in Japan (PG-MARJ) and the Allergic Rhinitis a...
Dementia in 2011: Microbleeds in dementia-singing a different ARIA.
New studies address urgent need for early COPD diagnosis.
Microfluidic diagnostics for the developing world.
For more than a decade, it has been expected that microfluidic technology would revolutionize the healthcare industry with simple, inexpensive, effective, and ubiquitous miniature diagnostic devices....
Disease severity impairs sleep quality in allergic rhinitis (The SOMNIAAR study).
BACKGROUND: Sleep is impaired in allergic rhinitis (AR) patients, with subsequent effects on daytime performance and health-related quality of life (QOL). Sleep quality in AR has rarely been considere...
